1. Ekstedt, M, Hagström, H, Nasr, P, et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology 2015; 61: 1547–1554.
Google Scholar | Crossref | Medline2. Hagström, H, Nasr, P, Ekstedt, M, et al. Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD. J Hepatol 2017; 67: 1265–1273.
Google Scholar | Crossref | Medline3. Dulai, PS, Singh, S, Patel, J, et al. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis. Hepatology 2017; 65: 1557–1565.
Google Scholar | Crossref | Medline4. Davison, BA, Harrison, SA, Cotter, G, et al. Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials. J Hepatol 2020; 73: 1322–1332.
Google Scholar | Crossref | Medline5. Tapper, EB, Loomba, R. Noninvasive imaging biomarker assessment of liver fibrosis by elastography in NAFLD. Nat Rev Gastroenterol Hepatol 2018; 15: 274–282.
Google Scholar | Crossref | Medline6. Loomba, R, Adams, LA. Advances in non-invasive assessment of hepatic fibrosis. Gut 2020; 69: 1343–1352.
Google Scholar | Crossref | Medline7. Yada, N, Tamaki, N, Koizumi, Y, et al. Diagnosis of fibrosis and activity by a combined use of strain and shear wave imaging in patients with liver disease. Dig Dis 2017; 35: 515–520.
Google Scholar | Crossref | Medline8. Honda, Y, Yoneda, M, Imajo, K, et al. Elastography techniques for the assessment of liver fibrosis in non-alcoholic fatty liver disease. Int J Mol Sci 2020; 521: 4039.
Google Scholar | Crossref9. Castéra, L, Foucher, J, Bernard, PH, et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology 2010; 51: 828–835.
Google Scholar | Medline | ISI10. Petta, S, Di Marco, V, Cammà, C, et al. Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index. Aliment Pharmacol Ther 2011; 33: 1350–1360.
Google Scholar | Crossref | Medline11. Wong, VW, Vergniol, J, Wong, GL-H, et al. Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease. Am J Gastroenterol 2012; 107: 1862–1871.
Google Scholar | Crossref | Medline | ISI12. Caussy, C, Chen, J, Alquiraish, MH, et al. Association between obesity and discordance in fibrosis stage determination by magnetic resonance vs transient elastography in patients with nonalcoholic liver disease. Clin Gastroenterol Hepatol 2018; 16: 1974–1982.e7.
Google Scholar | Crossref | Medline13. Wong, VW, Irles, M, Wong, GL, et al. Unified interpretation of liver stiffness measurement by M and XL probes in non-alcoholic fatty liver disease. Gut 2019; 68: 2057–2064.
Google Scholar | Crossref | Medline14. Vuppalanchi, R, Siddiqui, MS, Van Natta, ML, et al. Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease. Hepatology 2018; 67: 134–144.
Google Scholar | Crossref | Medline15. Ferraioli, G, Tinelli, C, Dal Bello, B, et al. Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: a pilot study. Hepatology 2012; 56: 2125–2133.
Google Scholar | Crossref | Medline | ISI16. Cassinotto, C, Lapuyade, B, Guiu, B, et al. Agreement between 2-dimensional shear wave and transient elastography values for diagnosis of advanced chronic liver disease. Clin Gastroenterol Hepatol 2020; 18: 2971–2979.e3.
Google Scholar | Crossref | Medline17. Paisant, A, Lemoine, S, Cassinotto, C, et al. Reliability criteria of two-dimensional shear wave elastography: analysis of 4277 measurements in 788 patients. Clin Gastroenterol Hepatol. Epub ahead of print 16 December 2020. DOI: 10.1016/j.cgh.2020.12.013.
Google Scholar | Crossref18. Cassinotto, C, Lapuyade, B, Mouries, A, et al. Non-invasive assessment of liver fibrosis with impulse elastography: comparison of supersonic shear imaging with ARFI and FibroScan®. J Hepatol 2014; 61: 550–557.
Google Scholar | Crossref | Medline19. Deffieux, T, Gennisson, JL, Bousquet, L, et al. Investigating liver stiffness and viscosity for fibrosis, steatosis and activity staging using shear wave elastography. J Hepatol 2015; 62: 317–324.
Google Scholar | Crossref | Medline | ISI20. Herrmann, E, de Lédinghen, V, Cassinotto, C, et al. Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: an individual patient data-based meta-analysis. Hepatology 2018; 67: 260–272.
Google Scholar | Crossref | Medline21. Leung, V, Shen, J, Wong, VW, et al. Quantitative elastography of liver fibrosis and spleen stiffness in chronic hepatitis B carriers: comparison of shear-wave elastography and transient elastography with liver biopsy correlation. Radiology 2013; 269: 910–918.
Google Scholar | Crossref | Medline22. Xiao, G, Zhu, S, Xiao, X, et al. Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: a meta-analysis. Hepatology 2017; 66: 1486–1501.
Google Scholar | Crossref | Medline23. Jamialahmadi, T, Nematy, M, Jangjoo, A, et al. Measurement of liver stiffness with 2D-shear wave elastography (2D-SWE) in bariatric surgery candidates reveals acceptable diagnostic yield compared to liver biopsy. Obes Surg 2019; 29: 2585–2592.
Google Scholar | Crossref | Medline24. Taibbi, A, Petta, S, Matranga, D, et al. Liver stiffness quantification in biopsy-proven nonalcoholic fatty liver disease patients using shear wave elastography in comparison with transient elastography. Ultrasonography 2021; 40: 407–416.
Google Scholar | Crossref | Medline25. Yoneda, M, Thomas, E, Sclair, SN, et al. Supersonic shear imaging and transient elastography with the XL probe accurately detect fibrosis in overweight or obese patients with chronic liver disease. Clin Gastroenterol Hepatol 2015; 13: 1502–1509.e5.
Google Scholar | Crossref | Medline26. Lee, DH, Cho, EJ, Bae, JS, et al. Accuracy of two-dimensional shear wave elastography and attenuation imaging for evaluation of patients with nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol 2021; 19: 797–805.e7.
Google Scholar | Crossref27. Furlan, A, Tublin, ME, Yu, L, et al. Comparison of 2D shear wave elastography, transient elastography, and MR elastography for the diagnosis of fibrosis in patients with nonalcoholic fatty liver disease. Am J Roentgenol 2020; 214: W20–W26.
Google Scholar | Crossref28. Cassinotto, C, Boursier, J, de Lédinghen, V, et al. Liver stiffness in nonalcoholic fatty liver disease: a comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy. Hepatology 2016; 63: 1817–1827.
Google Scholar | Crossref | Medline29. Imajo, K, Honda, Y, Kobayashi, T, et al. Direct comparison of US and MR elastography for staging liver fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. Epub ahead of print 17 December 2020. DOI: 10.1016/j.cgh.2020.12.016.
Google Scholar | Crossref30. Kleiner, DE, Brunt, EM, Van Natta, M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313–1321.
Google Scholar | Crossref | Medline | ISI31. Sandrin, L, Fourquet, B, Hasquenoph, JM, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003; 29: 1705–1713.
Google Scholar | Crossref | Medline | ISI32. Sporea, I, Gradinaru-Tascau, O, Boto, S, et al. How many measurements are needed for liver stiffness assessment by 2D-Shear Wave Elastography (2D-SWE) and which value should be used: the mean or median? Med Ultrason 2013; 15: 268–272.
Google Scholar | Crossref | Medline | ISI33. Boursier, J, Zarski, JP, de Ledinghen, V, et al. Determination of reliability criteria for liver stiffness evaluation by transient elastography. Hepatology 2013; 57: 1182–1191.
Google Scholar | Crossref | Medline | ISI34. von Elm, E, Altman, DG, Egger, M, et al. The Strengthening in the Reporting of Observations Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 2007; 147: 573–577.
Google Scholar | Crossref | Medline | ISI35. Castera, L, Friedrich-Rust, M, Loomba, R. Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Gastroenterology 2019; 156: 1264–1281.
Google Scholar | Crossref | Medline36. Eddowes, PJ, Sasso, M, Allison, M, et al. Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology 2019; 156: 1717–1730.
Google Scholar | Crossref | Medline37. Siddiqui, MS, Vuppalanchi, R, Van Natta, ML, et al. Vibration-controlled transient elastography to assess fibrosis and steatosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2019; 17: 156–163.e2.
Google Scholar | Crossref38. Maruyama, H, Kobayashi, K, Kiyono, S, et al. Two-dimensional shear wave elastography with propagation-based reliability assessment for grading hepatic fibrosis and portal hypertension. J Hepatobiliary Pancreat Sci 2016; 23: 595–602.
Google Scholar | Crossref | Medline39. Chen, J, Yin, M, Talwalkar, JA, et al. Diagnostic performance of MR elastography and vibration-controlled transient elastography in the detection of hepatic fibrosis in patients with severe to morbid obesity. Radiology 2017; 283: 418–428.
Google Scholar | Crossref | Medline40. Wan, T, Köhn, N, Kröll, D, et al. Applicability and results of liver stiffness measurement and controlled attenuation parameter using XL probe for metabolic-associated fatty liver disease in candidates to bariatric surgery. A single-center observational study. Obes Surg 2020; 31: 702–711.
Google Scholar | Crossref | Medline